New global infertility research partnership announced

Thermo Fisher Scientific and Predictive Laboratories are to collaborate on new global research into the genetic factors causing infertility in women, to interpret infertility genetics for development of non-invasive tests to support decision making, and to improve outcomes for women pursuing fertility treatment. The collaboration will take advantage of Thermo Fisher’s various offerings for reproductive health, including Applied Biosystems CarrierScan Assay, Ion ReproSeq PGS Assay, CytoScan Dx Assay, and Ion AmpliSeq Exome RDY for whole exome sequencing.
Yan Zhang, Thermo Fisher’s general manager, reproductive health, said: “We look forward to this exciting and important work with Predictive Laboratories to better understand infertility in women. With the combination of our partner’s expertise and our advanced solutions for genetic analysis, we are committed to reducing the future financial and emotional burden couples face while undergoing fertility treatment.”
Predictive Technology Group’s CEO, Bradley Robinson, said: “Infertility among women who seek to conceive has become an increasingly common condition, which leads to much frustration and financial burden as they seek alternative solutions. Our collaboration with Thermo Fisher brings together our innovative research and development capabilities with market-leading next generation sequencing technology to better understand the genetics of infertility for future development of a diagnostic solution.”